
Advertise on podcast: The Hematologist
Rating
4from
This podcast has
170 episodes
Language
EnglishPublisher
The HematologistExplicit
No
Date created
2015/07/08
Latest episode
2026/11/06
Average duration
22 min.
Release period
36 days
Description
The Hematologist is the member newsletter of American Society of Hematology (ASH). It is designed for the broad constituency of ASH, all working toward the ultimate goal of conquering blood diseases. The Hematologist updates readers about important developments in the field of hematology and highlights what ASH is doing for its members.
Unlock The Hematologist podcast Email contact info,
Listeners & Audience details
Email contact information
Direct podcast contact details

Listeners
Audience numbers & engagement insights

Audience details
Podcast Insights

Podcast episodes
Check latest episodes from The Hematologist podcast
One Size Doesn’t Fit All: International Consensus Recommendations for Pediatric Acute Myeloid Leukemia
2026/11/06
In this episode, contributing editor Dr. Lauren Pommert speaks with Dr. Sarah Tasian, pediatric oncologist at the Children’s Hospital of Philadelphia. They discuss the new International Consensus Recommendations for Pediatric Acute Myeloid Leukemia.
MonumenTAL and MajesTEC Steps Forward in Bispecific Antibodies for Relapsed Refractory Multiple Myeloma
2026/10/26
In this episode contributing editor Dr. Ajai Chari speaks with Dr. Roberto Mina, assistant professor of Hematology at Emory University about two recent myeloma studies published in the New England Journal of Medicine.
One on One With Mary Horowitz
2026/09/03
In this episode contributing editor, Lori Muffly, MD, MS, speaks with a celebrated leader in the field of bone marrow transplantation, Mary Horowitz, MD, MS, of the Medical College of Wisconsin.
A Secondary Consideration: How Real-World Evidence Can Inform Practice in the Management of Patients With Secondary CNS Lymphoma
2026/07/21
In this episode, Contributing Editor, Brian Hill, MD, speaks with Juan Alderuccio, MD, of the University of Miami Cancer Center, about a landmark study that supports refined treatment approaches for secondary central nervous system large B-cell lymphoma.
Targeting the Lectin Pathway in Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy
2026/06/16
In this episode, Contributing Editor Meera Sridharan, MD, PhD, speaks with Hiroyuki Matsui, MD, PhD, assistant professor in the department of hematology at Kyoto University Hospital in Japan. Their conversation focuses on the role of narsoplimab in treating a potentially fatal hematologic disorder.
Search for the Fountain of Youth: Can Bispecific Antibodies Resurrect Dysfunctional T Cells to Improve Outcomes in Richter Transformation?
2026/05/08
In this episode, Contributing Editor Tycel Phillips, MD, speaks with Arnon Kater, MD, of Amsterdam University Medical Center in the Netherlands. Their conversation focuses on the potential role of bispecific antibodies in managing patients with Richter transformation.
Not All Clots Are Created Equal: Refining Secondary Prevention of Venous Thromboembolism in Higher-Risk Patients
2026/04/30
In this episode, Michael Scott, MD, from the University of Toronto, St. Michael’s Hospital, speaks with Samuel Wilson, MD, of the University of North Carolina at Chapel Hill. Their conversation focuses on recent trials examining secondary prevention of venous thromboembolism in higher-risk patients.
Continuous Versus Fixed-Duration Treatment for Frontline Chronic Lymphocytic Leukemia
2026/04/09
In this episode, Contributing Editor Brian Hill, MD, PhD, speaks with Meghan Thompson, MD, of Memorial Sloan Kettering Cancer Center in New York. Their conversation focuses on Continuous Versus Fixed-Duration Treatment for Frontline Chronic Lymphocytic Leukemia.
VERONA and the Future of High-Risk Myelodysplastic Syndromes: A Conversation With Dr. Jacqueline Garcia
2026/03/09
In this episode, Contributing Editor Charlotte Brierley, MD, PhD, speaks with Jacqueline Garcia, MD, assistant professor at the Dana Farber Cancer Institute and Harvard Medical School and an expert in myeloid neoplasms. Their discussion focuses on the VERONA trial and its impact on the myelodysplastic syndromes community.
Leading With Lived Experience: Dr. Brian Koffman, Patient and CEO of the CLL Society
2026/02/05
In this episode Contributing Editor Brian Hill, MD, talks with Brian Koffman, MDCM, retired family doctor and chronic lymphocytic leukemia patient. Dr. Koffman is co-founder and chief medical officer of the CLL Society. They discuss Dr. Koffman’s journey as both a physician and a patient.
An Homage to the Treg Graft in Allogeneic Transplantation
2025/10/22
In this episode, Shaji Kumar, MD, editor-in-chief of The Hematologist, and consultant in hematology at Mayo Clinic in Rochester, Minnesota, talks with Robert Negrin, MD, professor of medicine at Stanford University and president-elect of ASH. They discuss recent developments in reducing graft versus host disease in allogenic stem cell transplant.
Less Is More: Low-Dose Direct Oral Anticoagulants for Extended Venous Thromboembolism Prophylaxis in Higher-Risk Patients
2025/09/11
In this episode, Contributing Editor Samuel Wilson, MD, talks with Francis Couturaud, MD, PhD, Professor of Pulmonology at University of Brest in France. They discuss low-dose direct oral anticoagulants for extended venous thromboembolism prophylaxis.
GATA Lot to Learn: Decoding the Drivers of Down Syndrome-Associated Acute Leukemias
2025/08/17
In this episode, Contributing Editor, Lauren Pommert, MD, MS, leads a conversation with Karen Rabin, MD, PhD, pediatric oncologist at the University of California, San Francisco, and Hans Hitzler, MD, with SickKids Children's Hospital in Toronto. They discuss advances in understanding the disease biology of down syndrome associated acute leukemia. Support for this episode provided by Autolus.
More Than Medicine: Peer Connection as a Therapeutic Adjunct in Acute Leukemia
2025/07/28
In this episode, Contributing Editor Lori Muffly, MD, MS, leads a conversation with two patients — Matt and Rohan — both of whom have undergone cord blood transplants for their acute myeloid leukemia. They discuss the value of peer connection as a vital component of their leukemia and transplant journey.
Pomalidomide: A Step on the PATH Forward for Treatment of Hereditary Hemorrhagic Telangiectasia
2025/06/23
In this episode, Contributing Editor Surbhi Shah, MBBS, MD, a clinician, researcher, and educator at Mayo Clinic in Phoenix, Arizona, talks with Keith McCrae, MD, director of classical hematology at the Taussig Cancer Institute and professor of molecular medicine at the Cleveland Clinic Lerner College of Medicine in Ohio. They discuss a recent paper co-authored by Dr. McCrae, “Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia.” Support for this episode provided by Autolus.
Podcast sponsorship advertising
Start advertising on The Hematologist relevant audience podcasts
You may also like to advertise on these Podcasts

51088171
Middle Children
Jessie Jolles and Chris Burns

4.8265192000
Morning Wire
The Daily Wire

4.518804384
American Scandal
Audible

4.689511232
Get Sleepy: Sleep meditation and stories
Slumber Studios

4.79026375
Life is Short with Justin Long
Audible

4.714149352
Bad Friends
Bobby Lee & Andrew Santino

4.7132874
10 to Life
Annie Elise

4.76762467
Criminology
Emash Digital & Mike Ferguson, Mike Morford

4.87552988
The Dr. John Delony Show
Ramsey Network

4.512663675
RedHanded
RedHanded